FIELD: medicine.
SUBSTANCE: one should affect with laser radiation at wave length being 514 nm. At first, it is necessary to fulfill coagulation of membranous border followed by affecting along the whole membranous surface at therapeutic dosages of 25-50 W/sq. cm power and exposure of 30 sec. The innovation restricts membranous area by preventing its growth to avoid hemorrhages.
EFFECT: higher efficiency of therapy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TOPOGRAPHICALLY ORIENTED LASER TREATMENT OF SUBACTIVE CHOROIDAL NEOVASCULAR MEMBRANES OF EXTRAFOVEAL LOCALIZATION ON A NAVIGATIONAL LASER UNIT | 2022 |
|
RU2777740C1 |
| CONTROLLED LASER COAGULATION METHOD FOR TREATING EYE RETINA DISEASES | 1996 |
|
RU2144342C1 |
| METHOD FOR THE TREATMENT OF ACTIVE CHOROIDAL NEOVASCULAR MEMBRANES OF EXTRAFOVEAL LOCALIZATION | 2022 |
|
RU2777739C1 |
| METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
| COMBINED METHOD FOR TREATING CHOROIDAL NEOVASCULATION OF ALL TYPES | 2021 |
|
RU2770745C1 |
| METHOD OF CURING SUBRETINAL NEOVASCULAR MEMBRANE | 2005 |
|
RU2290973C1 |
| METHOD OF COMBINED TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY CENTRAL RETINAL RUPTURE WITH ACCOMPANYING RETINOSCHISIS AND TRACTION-RHEGMATOGENOUS RETINAL DETACHMENT | 2023 |
|
RU2816782C1 |
| SURGERY TECHNIQUE FOR SUBRETINAL HAEMORRHAGES COMBINED WITH AGE-SPECIFIC MACULAR DYSTROPHY WITH SUBRETINAL NEOVASCULAR MEMBRANE | 2008 |
|
RU2366388C1 |
| SURGICAL METHOD FOR TREATING THE CASES OF SUBRETINAL NEOVASCULARIZATION DEVELOPED ON THE BACKGROUND OF CENTRAL RETINAL DYSTROPHY | 2003 |
|
RU2253420C1 |
| PHOTODYNAMIC METHOD FOR TREATING CHOROID NEOVASCULAR MEMBRANES | 2004 |
|
RU2274436C1 |
